Loading this company
HUTCHMED (China) Limited
HCMPrices in USD
TickerWorth ScoreD45/100
What we think
We do not publish a fair value for this company. The grade still applies.
Price
$14.22USD up +$0.17 (+1.21%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
We do not put a fair value on this one
Our cash-flow model doesn't produce a meaningful value for this business — its projected free cash flow is so far from supporting the current price that the result is effectively zero, which tells you about the limits of the model on a fast-growing or loss-making company, not about what the business is worth. Here is what we can show instead.
Is it a good business?
- Valuation50 out of 100
- Growth50 out of 100
- Financial health100 out of 100
- Past performance33 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$20.59 across 13 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It provides Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in Hong Kong. The company employs roughly 1,790 people.
Key stats
52-week range$9.77–$16.33
- Open
- $14.01
- Day high
- $14.19
- Day low
- $14.01
- Previous close
- $14.05
- Volume
- 7,677 · 0.11× avg
- Average volume
- 68,629
- Market cap
- $2,457,732,608.00
- P/E (TTM)
- 141.40
- Earnings per share
- $0.10
- Beta
- 0.36
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
No filings or corporate activity on file in the recent window.
Top news
No recent headlines we can cite for this company.
Insider trades
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.